La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Vir Biotechnology Bilan de santé
Santé financière contrôle des critères 6/6
Vir Biotechnology has a total shareholder equity of $1.4B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.7B and $235.9M respectively.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$1.15b |
| Fonds propres | US$1.43b |
| Total du passif | US$235.89m |
| Total des actifs | US$1.67b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analysts Are Updating Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimates After Its Second-Quarter Results
Aug 03
Bullish On Vir Biotechnology's Innovative Pipeline That Targets HIV And Hepatitis
Jul 17Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Boosting Their Estimates
May 05Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
May 03Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
Feb 28Sticking With Vir Biotechnology
Jan 17Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Slashed This Year's Revenue Estimates By 37%
Aug 07Revenues Working Against Vir Biotechnology, Inc.'s (NASDAQ:VIR) Share Price Following 42% Dive
Jul 24Analysts Just Shaved Their Vir Biotechnology, Inc. (NASDAQ:VIR) Forecasts Dramatically
Feb 28Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jan 07Vir Biotechnology: Focus On Hepatitis B Development Could End Up Paying Off
Oct 12Vir Biotech gains 12% as U.S. govt. inks multi-year deal worth up to $1B
Oct 04Vir begins dosing in mid-stage study of VIR-2218, VIR-3434 for hepatitis D virus
Sep 22Analyse de la situation financière
Passif à court terme: VIR's short term assets ($1.2B) exceed its short term liabilities ($96.4M).
Passif à long terme: VIR's short term assets ($1.2B) exceed its long term liabilities ($139.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: VIR is debt free.
Réduire la dette: VIR had no debt 5 years ago.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: VIR has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: VIR has sufficient cash runway for 2.1 years if free cash flow continues to grow at historical rates of 4.6% each year.